Duke University Health System President and CEO Dr. Victor Dzau was named president of the Institute of Medicine
, succeeding the longtime president, Dr. Harvey Fineberg
, the National Academy of Sciences announced Wednesday.
Dzau, whose six-year term will begin July 1, has done research
in the area of treatment for high blood pressure and congestive heart failure and pioneered the use of gene therapy for vascular disease, the institute said in announcing the selection. Dzau served on the IOM Council from 2008 through 2013, Fineberg said in a statement.
“As a physician-scientist and leader in academic medicine, Victor has consistently demonstrated inspirational leadership, innovative thinking and multifaceted achievement. Now, all of us at the IOM, both members and staff, will benefit more fully from his leadership,” said Fineberg, who has served as president of the institute for 12 years.
Commenting on his professional achievement, C.D. Mote Jr., president of the National Academy of Engineering, said of Dzau: “As science, engineering, and medicine are increasingly interconnected, Victor Dzau's foresight in advancing innovation and the translation of research into diagnostic methods, medicines, and creative solutions for human health issues will be a tremendous asset to the academies.”
In addition to being president of Duke's health system, Dzau is also chancellor for health affairs at Duke University and its James B. Duke professor of medicine.
“Harvey Fineberg has been an exceptional leader of the IOM, and I am committed to building on his outstanding work and advancing the impact of the IOM on the nation and globally,” Dzau said in a statement.Follow John N. Frank on Twitter: @MHJFrank